Blood Sugar News and Research

RSS

Blood sugar concentration, or glucose level, refers to the amount of glucose present in the blood of a human or animal. Normally, in mammals the blood glucose level is maintained at a reference range between about 3.6 and 5.8 mM (mmol/l). It is tightly regulated as a part of metabolic homeostasis.

Research reveals disparities in diabetes drug efficacy for Black populations

New research analyzing the effects of two drugs used to treat type 2 diabetes indicates a consistent lack of cardiovascular and renal benefits in Black populations.

23 Sep 2024

Study highlights disparities in stroke burden across regions

Although stroke is highly preventable and treatable, there has been a rapid rise in the global stroke burden between 1990 and 2021, due to both population growth and the rise of aging populations worldwide, as well as a substantial increase in people's exposure to environmental and behavioral risk factors.

19 Sep 2024

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

18 Sep 2024

Casual blood glucose test misses majority of gestational diabetes cases

When screening pregnant women for gestational diabetes, casual blood glucose testing misses 70% of the cases.

18 Sep 2024

Linking socioeconomic status and lifestyle to dementia risk

Researchers examine how socioeconomic status and healthy lifestyle factors interact to affect the risk of dementia.

18 Sep 2024

Study reveals sequential neuronal activation regulating food intake

The process of food intake appears to be organized at the cellular level like a relay race: during eating, the baton is passed between different teams of neurons until we have consumed the appropriate amount of energy.

17 Sep 2024

Assessing the impact of weight loss and blood sugar control in people with type 2 diabetes

A Cleveland Clinic research team has published the first study assessing the independent real-world impacts of weight loss and blood sugar control on clinical outcomes in people with type 2 diabetes treated with antidiabetic medications, and specifically with GLP-1RAs (the class of drug that includes Ozempic and Wegovy).

17 Sep 2024

Intensive diabetes treatment improves periodontal health

While the link between diabetes and periodontal disease is known, the impact of diabetes treatment on periodontal health is less well understood.

17 Sep 2024

Study reveals tropical oils' dual impact: Vital vitamins and dangerous side effects

A comprehensive review of tropical oils reveals their health benefits and risks, highlighting coconut and palm oil's impact on nutrition and disease prevention.

16 Sep 2024

Common diabetes medication slows growth of precancerous esophageal cells, study shows

A common diabetes medication, metformin, slows the growth of precancerous cells in the oesophagus while some metabolic conditions accelerate it, suggests a new study.

16 Sep 2024

Early pregnancy HbA1c predicts gestational diabetes, reducing the need for complex tests

Early pregnancy HbA1c can predict gestational diabetes and reduce the need for oral glucose tolerance tests, improving screening accessibility in diverse populations.

15 Sep 2024

Real-world data reveals factors associated with long-term weight loss in obesity

A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or obesity. The study was published in JAMA Network Open.

14 Sep 2024

Study reveals how SARS-CoV-2 triggers diabetes by destroying pancreatic cells

Researchers from Weill Cornell Medicine have used a cutting-edge model system to uncover the mechanism by which SARS-CoV-2, the virus that causes COVID-19, induces new cases of diabetes, and worsens complications in people who already have it.

13 Sep 2024

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Semaglutide and tirzepatide treatment lead to significant weight loss and improve blood sugar control in individuals with type 1 diabetes (T1D) who are living with overweight or obesity, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) has found.

13 Sep 2024

Advanced insulin pump technology improves diabetes management for marathon runners

A series of case reports to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), describe how a technology giving insulin doses informed by an insulin pump algorithm helped three adults with type 1 diabetes better manage their blood sugars enabling them to lead more active lives, and even run marathons.

13 Sep 2024

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

13 Sep 2024

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged.

12 Sep 2024

Fear of hypoglycemia limits physical activity in adults with type 1 diabetes

Despite high use of continuous glucose monitoring and insulin pump therapy, fear of hypoglycemia (low blood sugar) remains a significant barrier to physical activity and exercise for adults with type 1 diabetes (T1D), according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

12 Sep 2024

Swift management of gestational diabetes lowers child obesity rates

Swiftly achieving glycemic control after a diagnosis of gestational diabetes can bring the baby's risk obesity in childhood down to a level similar to that of children whose mothers did not have gestational diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), has found.

12 Sep 2024

New research aims to target IL-6 for treating diabetic retinopathy

Scientists at the Medical College of Georgia at Augusta University are searching for a new treatment target for a common complication of diabetes that can cause retinal blood vessels to break down, leak, or become blocked.

12 Sep 2024

Blood Sugar News and Research

Further Reading

Research reveals disparities in diabetes drug efficacy for Black populations

Study highlights disparities in stroke burden across regions

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

Casual blood glucose test misses majority of gestational diabetes cases

Linking socioeconomic status and lifestyle to dementia risk

Study reveals sequential neuronal activation regulating food intake

Assessing the impact of weight loss and blood sugar control in people with type 2 diabetes

Intensive diabetes treatment improves periodontal health

Study reveals tropical oils' dual impact: Vital vitamins and dangerous side effects

Common diabetes medication slows growth of precancerous esophageal cells, study shows

Early pregnancy HbA1c predicts gestational diabetes, reducing the need for complex tests

Real-world data reveals factors associated with long-term weight loss in obesity

Study reveals how SARS-CoV-2 triggers diabetes by destroying pancreatic cells

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Advanced insulin pump technology improves diabetes management for marathon runners

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

Fear of hypoglycemia limits physical activity in adults with type 1 diabetes

Swift management of gestational diabetes lowers child obesity rates

New research aims to target IL-6 for treating diabetic retinopathy

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News